English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

DAB389IL-2 is a genetically engineered fusion protein that reduces human immunodeficiency virus type 1 (HIV-1) replication in activated, interleukin (IL)-2 receptor (IL-2R)-expressing human peripheral blood mononuclear cells (PBMC). The level of infectious virus released by cultured PBMC after treatment with DAB389IL-2 was measured by a quantitative microculture assay. The inhibition of p24 antigen production was also evaluated in cultures that differed in duration of infection and activation state. Although the activation state of the cell and the time of DAB389IL-2 addition to the cultures influenced its anti-HIV activity, DAB389IL-2 treatment decreased levels of infectious HIV-1 to 0.1%-6.5% of untreated cell levels. DAB389IL-2 also decreased p24 antigen expression to 10%-48% of controls, even when added as late as 8 days after acute infection. Mutational variants of DAB389IL-2 that lack catalytic activity or IL-2R binding are without anti-HIV activity.

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

The Interleukin‐2 Fusion Protein, DAB<sub>389</sub>IL‐2, Inhibits the Development of Infectious Virus in Human Immunodeficiency Virus Type 1‐Infected Human Peripheral Blood Mononuclear Cells

The Interleukin‐2 Fusion Protein, DAB389IL‐2, Inhibits the Development of Infectious Virus in Human Immunodeficiency Virus Type 1‐Infected Human Peripheral Blood Mononuclear Cells

The Interleukin‐2 Fusion Protein, DAB₃₈₉IL‐2, Inhibits the Development of Infectious Virus in Human Immunodeficiency Virus Type 1‐Infected Human Peripheral Blood Mononuclear Cells